227 related articles for article (PubMed ID: 36737789)
21. Multifunctional profiling of triple-negative breast cancer patient-derived tumoroids for disease modeling.
Cromwell EF; Sirenko O; Nikolov E; Hammer M; Brock CK; Matossian MD; Alzoubi MS; Collins-Burow BM; Burow ME
SLAS Discov; 2022 Apr; 27(3):191-200. PubMed ID: 35124274
[TBL] [Abstract][Full Text] [Related]
22. Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs.
Watson J; Wang T; Ho KL; Feng Y; Dobbin KK; Zhao S
bioRxiv; 2023 Mar; ():. PubMed ID: 37034591
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous breast tumoroids: An in vitro assay for investigating cellular heterogeneity and drug delivery.
Vamvakidou AP; Mondrinos MJ; Petushi SP; Garcia FU; Lelkes PI; Tozeren A
J Biomol Screen; 2007 Feb; 12(1):13-20. PubMed ID: 17166827
[TBL] [Abstract][Full Text] [Related]
24. Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor.
Park HM; Kim H; Kim DW; Yoon JH; Kim BG; Cho JY
BMB Rep; 2020 Dec; 53(12):664-669. PubMed ID: 33298249
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors.
Bergholtz H; Lien T; Lingaas F; Sørlie T
J Mammary Gland Biol Neoplasia; 2022 Jun; 27(2):171-183. PubMed ID: 35932380
[TBL] [Abstract][Full Text] [Related]
26. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.
Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD
J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
28. Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma.
Rosen S; Brisson BK; Durham AC; Munroe CM; McNeill CJ; Stefanovski D; Sørenmo KU; Volk SW
PLoS One; 2020; 15(8):e0236516. PubMed ID: 32776970
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
31. Canine mammary tumours as a model to study human breast cancer: most recent findings.
Queiroga FL; Raposo T; Carvalho MI; Prada J; Pires I
In Vivo; 2011; 25(3):455-65. PubMed ID: 21576423
[TBL] [Abstract][Full Text] [Related]
32. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
33. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system.
van Garderen E; Schalken JA
Mol Cell Endocrinol; 2002 Nov; 197(1-2):153-65. PubMed ID: 12431808
[TBL] [Abstract][Full Text] [Related]
34. A role for T-lymphocytes in human breast cancer and in canine mammary tumors.
Carvalho MI; Pires I; Prada J; Queiroga FL
Biomed Res Int; 2014; 2014():130894. PubMed ID: 24672781
[TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of a canine mammary cell line prepared for proteomics analysis.
Zamani-Ahmadmahmudi M; Nassiri SM; Jahanzad I; Shirani D; Rahbarghazi R; Yazdani B
Tissue Cell; 2013 Jun; 45(3):183-90. PubMed ID: 23375365
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of a new triple-negative canine mammary cancer cell line.
Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D
Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498
[TBL] [Abstract][Full Text] [Related]
37. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
[TBL] [Abstract][Full Text] [Related]
38. Relationship between the inflammatory tumor microenvironment and different histologic types of canine mammary tumors.
de Souza TA; de Campos CB; De Biasi Bassani Gonçalves A; Nunes FC; Monteiro LN; de Oliveira Vasconcelos R; Cassali GD
Res Vet Sci; 2018 Aug; 119():209-214. PubMed ID: 29966962
[TBL] [Abstract][Full Text] [Related]
39. Artificial tumor matrices and bioengineered tools for tumoroid generation.
Liu YC; Chen P; Chang R; Liu X; Jhang JW; Enkhbat M; Chen S; Wang H; Deng C; Wang PY
Biofabrication; 2024 Mar; 16(2):. PubMed ID: 38306665
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of cancer stem cell-based tumoroids as an osteosarcoma model.
Ozturk S; Gorgun C; Gokalp S; Vatansever S; Sendemir A
Biotechnol Bioeng; 2020 Aug; 117(8):2527-2539. PubMed ID: 32391924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
